HOXA10 and invasive ductal breast carcinoma: HOXA10 is methylated in differentiated CD24-positive normal mammary cells and luminal BC cells [36], and the methylation level increases during the progression of BC from DCIS via a primary invasive ductal carcinoma, to a metastatic tumor [36, 37].